Agilent stock slips as coronavirus dings outlook

Agilent Techonologies Inc. shares declined in the extended session Tuesday after the lab instruments maker said its outlook would be impacted by the novel coronavirus. Agilent shares declined 1% after hours, following a 1.2% decline in the regular session to close at $84.79. Agilent expects earnings of 72 cents to 76 cents a share on revenue of $1.28 billion to $1.32 billion, while analysts had forecast earnings of 79 cents a share on revenue of $1.34 billion, "after factoring in the potential impact of the coronavirus disease 2019 (COVID-19)," the company said in a statement. The company reported fiscal first-quarter net income of $197 million, or 63 cents a share, compared with $504 million, or $1.57 a share, in the year-ago period. Adjusted earnings were 81 cents a share. Revenue rose to $1.36 billion from $1.28 billion in the year-ago quarter. Analysts surveyed by FactSet had forecast earnings of 81 cents a share on revenue of $1.35 billion.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.